Eversept Partners, LP Infla Rx N.V. Transaction History

Eversept Partners, LP

  • $1.29 Billion
  • Q3 2025

A detailed history of Eversept Partners, LP transactions in Infla Rx N.V. stock. As of the latest transaction made, Eversept Partners, LP holds 1,730,635 shares of IFRX stock, worth $2.3 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
1,730,635
Previous 1,640,430 5.5%
Holding current value
$2.3 Million
Previous $1.3 Million 75.06%
% of portfolio
0.18%
Previous 0.13%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$0.8 - $1.73 $72,164 - $156,054
90,205 Added 5.5%
1,730,635 $2.27 Million
Q2 2025

Aug 14, 2025
SELL
$0.73 - $1.85 $25,950 - $65,763
-35,548 Reduced 2.12%
1,640,430 $1.3 Million
Q1 2025

May 15, 2025
BUY
$1.02 - $2.62 $1.21 Million - $3.1 Million
1,183,526 Added 240.33%
1,675,978 $1.71 Million
Q4 2024

Feb 14, 2025
SELL
$1.38 - $2.64 $1.56 Million - $2.98 Million
-1,129,335 Reduced 69.64%
492,452 $1.23 Million
Q3 2024

Nov 14, 2024
BUY
$1.34 - $1.73 $73,508 - $94,902
54,857 Added 3.5%
1,621,787 $2.48 Million
Q2 2024

Aug 14, 2024
BUY
$1.18 - $1.74 $308,912 - $455,514
261,790 Added 20.06%
1,566,930 $2.73 Million
Q4 2023

Feb 14, 2024
SELL
$1.25 - $2.75 $540,505 - $1.19 Million
-432,404 Reduced 24.89%
1,305,140 $2.13 Million
Q3 2023

Nov 14, 2023
SELL
$2.66 - $4.33 $472,333 - $768,873
-177,569 Reduced 9.27%
1,737,544 $5.18 Million
Q2 2023

Aug 14, 2023
BUY
$2.05 - $6.1 $3.93 Million - $11.7 Million
1,915,113 New
1,915,113 $8.54 Million
Q2 2021

Aug 16, 2021
SELL
$2.72 - $4.04 $730,684 - $1.09 Million
-268,634 Closed
0 $0
Q1 2021

Nov 08, 2023
SELL
$3.62 - $6.34 $5.96 Million - $10.4 Million
-1,646,479 Reduced 85.97%
268,634 $1.05 Million
Q1 2021

May 13, 2021
BUY
$3.62 - $6.34 $972,455 - $1.7 Million
268,634 New
268,634 $1.05 Million
Q2 2020

Aug 13, 2020
SELL
$4.59 - $8.96 $897,289 - $1.75 Million
-195,488 Closed
0 $0
Q1 2020

Nov 08, 2023
SELL
$2.65 - $6.08 $368,694 - $845,910
-139,130 Reduced 41.58%
195,488 $746,000
Q1 2020

May 13, 2020
SELL
$2.65 - $6.08 $368,694 - $845,910
-139,130 Reduced 41.58%
195,488 $747,000
Q4 2019

Nov 08, 2023
SELL
$2.2 - $4.54 $3.48 Million - $7.18 Million
-1,580,495 Reduced 82.53%
334,618 $1.33 Million
Q4 2019

Feb 13, 2020
BUY
$2.2 - $4.54 $736,159 - $1.52 Million
334,618 New
334,618 $1.33 Million

Others Institutions Holding IFRX

# of Institutions
31
Shares Held
19.2M
Call Options Held
52K
Put Options Held
0
View Full List

About InflaRx N.V.

IFRX Quotes by TradingView
  • Ticker IFRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,203,800
  • Market Cap $58.8M
  • Description
  • InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...
More about IFRX
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email